Multiple Sclerosis (MS) is a chronic inflammatory disease of the Central Nervous System characterized by immune-mediated demyelination, axonal damage, and progressive neurodegeneration, which critically contributes to irreversible disability. Currently, disease-modifying therapies are effective in treating inflammatory...
Greta Paolilli Treonze, Erjola Bej, M. Catanesi et al.· Applied Sciences· 0 citations
It is demonstrated that rhNGF ameliorates visual acuity loss, preserves retinal thickness, sustains RGC survival, and reduces oxidative stress and neuroinflammation both in early-stage and fully developed disease.
Davide Vecchiotti, M. Di Vito Nolfi, Chiara Compagnoni et al.· Cell Death Discovery· 0 citations
Computational strategies ranging from machine learning-guided sequence optimization to structure prediction and generative AI have accelerated the rational design of aptamers tailored to GBM specific challenges, enabling the development of innovative aptamer drug conjugates for targeted delivery to GBM cells.
L. Di Leandro, Martina Colasante, M. Catanesi et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.